novo-tolmetin capsules 400mg
novopharm limited - tolmétin (tolmétine sodique) - capsule - 400mg - tolmétin (tolmétine sodique) 400mg - other nonsteroidal antiimflammatory agents
mekinist
novartis europharm limited - trametinib - mélanome - agents antinéoplasiques - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 et 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non-small cell lung cancer (nsclc)trametinib en combinaison avec le dabrafenib est indiqué pour le traitement de patients adultes atteints avancé non à petites cellules, le cancer du poumon avec une mutation de braf v600.
mektovi
pierre fabre medicament - binimetinib - mélanome - agents antinéoplasiques - binimetinib en combinaison avec encorafenib est indiqué pour le traitement de patients adultes atteints de mélanome non résécable ou métastatique avec mutation de braf v600.
koselugo 10 mg gélules
alexion pharma gmbh - selumetinibum - gélules - selumetinibum 10 mg ut selumetinibi hydrogenosulfas, tocofersolanum, kapselhülle: hypromellosum, carrageenanum, kalii chloridum, e 171, aqua purificata, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - neurofibromatose typ 1 (nf+) und plexiforme neurofibrome (pn) - synthetika
koselugo 25 mg gélules
alexion pharma gmbh - selumetinibum - gélules - selumetinibum 25 mg ut selumetinibi hydrogenosulfas, tocofersolanum, kapselhülle: hypromellosum, carrageenanum, kalii chloridum, e 171, e 132, e 172 (flavum), aqua purificata, cera carnauba, maydis amylum, drucktinte: e 172 (rubrum), e 172 (flavum), e 132, cera carnauba, lacca, glyceroli mono-oleas, pro capsula. - neurofibromatose typ 1 (nf+) und plexiforme neurofibrome (pn) - synthetika
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agents antinéoplasiques - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
mekinist comprimé
novartis pharmaceuticals canada inc - tramétinib - comprimé - 0.5mg - tramétinib 0.5mg - antineoplastic agents
mekinist comprimé
novartis pharmaceuticals canada inc - tramétinib - comprimé - 1mg - tramétinib 1mg - antineoplastic agents
mekinist comprimé
novartis pharmaceuticals canada inc - tramétinib - comprimé - 2mg - tramétinib 2mg - antineoplastic agents
mektovi comprimé
pfizer canada ulc - binimétinib - comprimé - 15mg - binimétinib 15mg - antineoplastic agents